Pfizer secured a reprieve from President Donald Trump’s long-threatened tariffs on the pharmaceutical industry by agreeing to slash some of its drug prices by up to 85% and selling directly to the ...

Newly disclosed agreements show that lower U.S. drug prices were only one side of the bargain. Pfizer and Eli Lilly also received tariff protection and other commitments, while extensive redactions ...

President Trump said he expects to reach pricing deals with more drug companies following the Pfizer announcement.

Drugmaker Pfizer has agreed to lower drug costs and invest $70 billion in U.S. manufacturing under a deal struck with ...

Pfizer CEO Albert Bourla (L) speaks in the White House as Medicare and Medicaid Administrator Mehmet Oz and US President Donald Trump look on during an announcement ...

In a surprising turnaround, Pfizer said Tuesday that it will defer raising prices on multiple drugs after heavy pressure from President Donald Trump. The pharmaceutical company’s announcement came ...

When President Trump talks about accomplishments of his second term, he often mentions the deals he's struck with pharmaceutical companies to lower drug prices. "We went from the highest prescription ...

U.S. President Donald Trump's announcement that all 50 states will join his proposed drug-price lowering policy is leading Canadian pharmaceutical experts and international researchers to warn how ...

NEW YORK, October 2 (Reuters) -Eli Lilly was asked to produce more insulin; Pfizer to produce more of its top-selling cancer drug Ibrance and its cholesterol drug Lipitor; and London-based AstraZeneca ...

President Donald Trump's pharmaceutical holdings reached a disclosed maximum of $56.2 million (€50 million and £42.3 million) ...